Detalles de la búsqueda
1.
Alterations of redox and iron metabolism accompany the development of HIV latency.
EMBO J
; 39(9): e102209, 2020 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32157726
2.
Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial.
AIDS Res Ther
; 19(1): 2, 2022 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35022035
3.
Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.
J Virol
; 89(15): 7521-35, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25972547
4.
Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS.
Retrovirology
; 12: 51, 2015 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-26084487
5.
Cell-mediated anti-Gag immunity in pharmacologically induced functional cure of simian AIDS: a 'bottleneck effect'?
J Med Primatol
; 44(5): 227-40, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26058990
6.
A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model.
PLoS Pathog
; 8(6): e1002774, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22737073
7.
A cure for AIDS: a matter of timing?
Retrovirology
; 10: 145, 2013 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-24267982
8.
Investigational treatment suspension and enhanced cell-mediated immunity at rebound followed by drug-free remission of simian AIDS.
Retrovirology
; 10: 71, 2013 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23866829
9.
A scalable workflow to test "shock and kill" therapeutic approaches against the HIV-1 latent reservoir in blood cells ex vivo.
STAR Protoc
; 4(2): 102253, 2023 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37097819
10.
Therapeutic imprinting of the immune system: towards a remission of AIDS in primates?
Retrovirology
; 9: 75, 2012 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-22978787
11.
The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters.
mBio
; 13(2): e0370521, 2022 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35229634
12.
Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria.
Am J Pathol
; 176(1): 205-17, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20019192
13.
Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stress.
EMBO Mol Med
; 13(8): e13901, 2021 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34289240
14.
Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy.
Retrovirology
; 7: 21, 2010 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-20233398
15.
Pharmacokinetic Basis of the Hydroxychloroquine Response in COVID-19: Implications for Therapy and Prevention.
Eur J Drug Metab Pharmacokinet
; 45(6): 715-723, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32780273
16.
A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus?
Int J Antimicrob Agents
; 56(3): 106078, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32629115
17.
NHC-gold compounds mediate immune suppression through induction of AHR-TGFß1 signalling in vitro and in scurfy mice.
Commun Biol
; 3: 10, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31909202
18.
"Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence.
Retrovirology
; 6: 52, 2009 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-19486542
19.
Crossroads of Cancer and HIV-1: Pathways to a Cure for HIV.
Front Immunol
; 10: 2267, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31636630
20.
Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial.
Int J Antimicrob Agents
; 54(5): 592-600, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31394172